Zimbabwe has declined a substantial American health deal valued at $367m (272 million pounds) spanning five years over Washington's insistence on confidential data.
This move was revealed following a official document from December was disclosed, which showed President Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesman has since stated that the United States was seeking genetic material for scientific study and profit while was not willing to share the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable task of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further dialogue to secure a deal suitable to both sides so the nation's critical HIV programme can continue.
Wider Implications
This rejection follows a comparable case in Kenya, where a high court blocked a similar deal with the US following legal challenges were filed about the safety of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral deals to boost openness and responsibility.
As per statements, Sixteen African countries have to date agreed to similar health pacts, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy via American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information over an extended period, without any corresponding assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," he stated.
"Effectively, our country would supply the raw materials for medical research with no assurance that the final treatments would be available to our citizens if a new pandemic arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting frameworks already set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage future pandemics.
"This framework is designed to ensure that when a nation contributes its information, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage further discussions with our US partners on how subsequent collaboration could be structured in a way that honours the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but recommended that negotiations should continue given that much of the nation's HIV programmes relied on foreign aid.
"In cases where technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed via technical clarification and negotiated safeguards," it commented.
The situation emphasises the continuing tensions between accepting much-needed international aid and protecting local interests in an ever more interconnected world.